RSS

companion diagnostics

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Innovative molecular diagnostics company, Biocartis Group, and biotechnology company, Amgen, have signed a new companion diagnostic (CDx) development agreement for a novel oncology compound. more

News

Molecular diagnostics company, Biocartis, has signed a companion diagnostic (CDx) development agreement with biotechnology company, Amgen, for the Idylla RAS biomarker tests. more

News

With the implementation of the new European Union In Vitro Diagnostic Regulation (EU IVDR) commencing, questions have been raised on companion diagnostic (CDx) development, which were assessed at a recent meeting held by ARC Regulatory. more

News

The companies will co-development and commercialise a liquid biopsy-based companion diagnostic to be paired with Iressa, AZ's targeted therapy for non-small cell lung cancer. more

Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018. more

News